Literature DB >> 23800475

Neurocognitive functioning in bipolar depression: a component structure analysis.

P Gallagher1, J M Gray1, S Watson1, A H Young2, I N Ferrier1.   

Abstract

BACKGROUND: Previous studies of neurocognitive performance in bipolar disorder (BD) have focused predominantly on euthymia. In this study we aimed to compare the neurocognitive profile of BD patients when depressed with healthy controls and explore the component structure of neurocognitive processes in these populations.
METHOD: Cognitive tests of attention and executive function, immediate memory, verbal and visuospatial learning and memory and psychomotor speed were administered to 53 patients with a SCID-verified diagnosis of BD depression and 47 healthy controls. Test performance was assessed in terms of statistical significance, effect size and percentile standing. Principal component analysis (PCA) was used to explore underlying cognitive factor structure.
RESULTS: Multivariate analysis revealed an overall group effect, depressed BD patients performing significantly worse than controls. Patients performed significantly worse on 18/26 measures examined, with large effect sizes (d > 0.8) on tests of speed of processing, verbal learning and specific executive/working memory processes. Almost all tests produced at least one outcome measure on which ∼25-50% of the BD sample performed at more than 1 standard deviation (s.d.) below the control mean. Between 20% and 34% of patients performed at or below the fifth percentile of the control group in working memory, verbal learning and memory, and psychomotor/processing speed. PCA highlighted overall differences between groups, with fewer extracted components and less specificity in patients.
CONCLUSIONS: Overall, neurocognitive test performance is significantly reduced in BD patients when depressed. The use of different methods of analysing cognitive performance is highlighted, along with the relationship between processes, indicating important directions for future research.

Entities:  

Mesh:

Year:  2013        PMID: 23800475     DOI: 10.1017/S0033291713001487

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  11 in total

Review 1.  Medication nonadherence in bipolar disorder: a narrative review.

Authors:  Ibrahim Jawad; Stuart Watson; Peter M Haddad; Peter S Talbot; R Hamish McAllister-Williams
Journal:  Ther Adv Psychopharmacol       Date:  2018-10-16

Review 2.  Neuroendocrine Stress System in Bipolar Disorder.

Authors:  Mario F Juruena; Anthony J Cleare; Allan H Young
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 3.  Neurocognitive impairment and evidence-based treatment options in Bipolar disorder.

Authors:  Konstantinos N Fountoulakis
Journal:  Ann Gen Psychiatry       Date:  2020-09-23       Impact factor: 3.455

4.  Cognitive deficits in bipolar disorder: from acute episode to remission.

Authors:  J Volkert; M A Schiele; Julia Kazmaier; Friederike Glaser; K C Zierhut; J Kopf; S Kittel-Schneider; A Reif
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-11-26       Impact factor: 5.270

5.  The neurocognitive functioning in bipolar disorder: a systematic review of data.

Authors:  Eirini Tsitsipa; Konstantinos N Fountoulakis
Journal:  Ann Gen Psychiatry       Date:  2015-12-01       Impact factor: 3.455

6.  The Factor Structure of Cognitive Functioning in Cognitively Healthy Participants: a Meta-Analysis and Meta-Analysis of Individual Participant Data.

Authors:  Joost A Agelink van Rentergem; Nathalie R de Vent; Ben A Schmand; Jaap M J Murre; Janneke P C Staaks; Hilde M Huizenga
Journal:  Neuropsychol Rev       Date:  2020-02-01       Impact factor: 7.444

7.  Neuropsychology of Bipolar Disorder.

Authors:  Peter Gallagher
Journal:  Curr Top Behav Neurosci       Date:  2021

8.  The Impact of Target Frequency on Intra-Individual Variability in Euthymic Bipolar Disorder: A Comparison of Two Sustained Attention Tasks.

Authors:  Rachel Ann Moss; Andreas Finkelmeyer; Lucy J Robinson; Jill M Thompson; Stuart Watson; I Nicol Ferrier; Peter Gallagher
Journal:  Front Psychiatry       Date:  2016-06-16       Impact factor: 4.157

9.  Are current chronic fatigue syndrome criteria diagnosing different disease phenotypes?

Authors:  Laura Maclachlan; Stuart Watson; Peter Gallagher; Andreas Finkelmeyer; Leonard A Jason; Madison Sunnquist; Julia L Newton
Journal:  PLoS One       Date:  2017-10-20       Impact factor: 3.240

10.  Comparison of Cerebellar Grey Matter Alterations in Bipolar and Cerebellar Patients: Evidence from Voxel-Based Analysis.

Authors:  Michela Lupo; Giusy Olivito; Andrea Gragnani; Marco Saettoni; Libera Siciliano; Corinna Pancheri; Matteo Panfili; Marco Bozzali; Roberto Delle Chiaie; Maria Leggio
Journal:  Int J Mol Sci       Date:  2021-03-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.